Direct-acting antiviral (DAA) therapy is highly efficacious for the treatment of hepatitis C virus (HCV) infection in older adults; however, those aged ≥75 years are more likely to have clinically significant pretreatment drug-drug interactions (DDIs) and experience adverse events (AEs) during therapy. This according to a retrospective review between June 2014 and January 2017 that included individuals aged ≥65 years treated with DAA therapy for HCV during the study period (n=113) divided into 2 cohorts: aged 65 to 74 years (n=88) and aged ≥75 years (n=25). DDIs, AEs, and rates of sustained virologic response (SVR) with DAA therapy were assessed. Among the findings:
- SVR rate was 97.7% in those aged 65 to 74 years and 95.8% in those aged ≥75 years.
- Individuals aged ≥75 years were more likely to be taking >2 medications per day for chronic conditions and more likely to have clinically significant DDIs necessitating cessation or adjustment of medications before inauguration of DAA therapy.
- Those aged ≥75 years were also more likely to experience an AE during therapy.
Mazzarelli C, Considine A, Childs K, et al. Efficacy and tolerability of direct-acting antivirals for hepatitis C in older adults. [Published online ahead of print May 25, 2018]. J Am Geriatr Soc. doi:10.1111/jgs.15392.
This Week's Must Reads
Increased Water Intake in Premenopausal Women with UTIs, JAMA Intern Med; ePub 2018 Oct 1; Hooton, et al
Adverse Childhood Experiences & Weight Status, J Pediatr; ePub 2018 Oct 1; Davis, Barnes, et al
Prevalence of E-Cigarette Use Among US Adults, Ann Intern Med; 2018 Oct 2; Mirbolouk, et al
Continuous Combined Oral Contraceptives & VTE Risk, JAMA Intern Med; ePub 2018 Oct 1; Li, et al
Wearable Cardioverter-Defibrillator Use After MI, N Engl J Med; 2018 Sep 27; Olgin, et al
Must Reads in Hepatitis
Limited Coverage of HCV Testing in US Since 2013, Clin Infect Dis; ePub 2018 Sep 15; Patel, et al
Smoking Status & Pain in Veterans with HCV, Pain Med; ePub 2018 Sep 7; Lynch, et al
Assessing the HCV Care Cascade in Baby Boomers, Am J Manag Care; 2018 Sep; Brady, Vellozzi, et al
HCV Screening in Elective Cranial Neurosurgery, J Neurosurg; 2018 Sep; Nussbaum, Kallmes, et al
Young Adults Who Inject Drugs & Risk of HCV, Health Promot Pract; ePub 2018 Sep 18; Knight, et al